Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled date : 2021 - 07 - 06 save search
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
Published: 2021-07-06 (Crawled : 19:00) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: -1.05%
H: 1.06%
C: -12.02%
treatment fda phase 2 opioid osteoarthritis trial fda clearance
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi SyndromeFDA agrees to review additional data to determine adequacy for submission of NDA
Published: 2021-07-06 (Crawled : 17:00) - biospace.com/
SLNO 4 | $37.15 -1.98% -2.02% 260K
|
Health Technology
|
| O: -0.91%
H: 0.92%
C: -2.75%
treatment fda submission
ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis
Published: 2021-07-06 (Crawled : 16:00) - biospace.com/
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: 1.88%
H: 8.94%
C: 3.77%
treatment pdufa submission avacopan
Diality Poised to Revolutionize Dialysis Treatment - In Development of Versatile Home Dialysis System; Welcomes Industry Veteran Dan Guthrie as Chief Business Officer
Published: 2021-07-06 (Crawled : 13:15) - biospace.com/
ZBH | $119.33 -1.62% 0.0% 1.4M
|
Health Technology
|
| O: -0.58%
H: 0.37%
C: -0.04%
MDT | $79.19 0.14% -0.57% 5.1M
|
Health Technology
|
| O: 0.87%
H: 0.2%
C: 0.13%
treatment dialysis
Arrowhead Announces Positive Interim Results from Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
Published: 2021-07-06 (Crawled : 13:00) - biospace.com/
ARWR | $22.61 0.36% 0.4% 1.3M
|
Health Technology
|
| O: -3.19%
H: 3.74%
C: -2.98%
treatment phase 1 renal positive results phase 1b phase 2b cell carcinoma
Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s DiseaseStudy Extension allows for additional 26 weeks of treatment on ATH-1017
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
ATHA | $2.06 -2.37% -1.93% 190K
|
Health Technology
|
| O: 1.15%
H: 5.59%
C: 4.17%
disease alzheimer treatment clinical trials trial ath-1017 alzheimer’s alzheimer's
Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: -6.69%
H: 1.46%
C: -6.05%
treatment fda cancer breast cancer metastatic breast cancer
GE Healthcare and SOPHiA GENETICS to collaborate to match treatments to multimodal patient data and cancer type
Published: 2021-07-06 (Crawled : 11:00) - prnewswire.com
GE | $152.94 -1.75% -0.39% 4.9M
|
Electronic Technology
|
| O: -1.78%
H: 0.3%
C: -2.71%
treatment genetic cancer oda collaboration
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Ophthalmic Disease
Published: 2021-07-06 (Crawled : 11:00) - globenewswire.com
MNOV | $1.4 -2.1% 1.04% 21K
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: -5.0%
disease treatment patent mn-166
Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis (MF)
Published: 2021-07-06 (Crawled : 00:00) - prnewswire.com
KPTI | $1.28 -7.25% -9.09% 1.3M
|
Health Technology
|
| O: -0.93%
H: 0.28%
C: -4.62%
treatment fibrosis china trial
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.